These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 9673345

  • 1. Immunocytochemical localization of an immunoconjugate (antibody IgG against prostatic acid phosphatase conjugated to 5-fluoro-2'-deoxyuridine) in human prostate tumors.
    Sinha AA, Quast BJ, Wilson MJ, Reddy PK, Fernandes ET, Ewing SL, Gleason DF.
    Anticancer Res; 1998; 18(3A):1385-92. PubMed ID: 9673345
    [Abstract] [Full Text] [Related]

  • 2. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
    Sinha AA, Sackrison JL, DeLeon OF, Wilson MJ, Gleason DF.
    Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
    [Abstract] [Full Text] [Related]

  • 3. Intravenous injection of an immunoconjugate (anti-PSA-IgG conjugated to 5-fluoro-2'-deoxyuridine) selectively inhibits cell proliferation and induces cell death in human prostate cancer cell tumors grown in nude mice.
    Sinha AA, Quast BJ, Reddy PK, Elson MK, Wilson MJ.
    Anticancer Res; 1999 Aug; 19(2A):893-902. PubMed ID: 10368631
    [Abstract] [Full Text] [Related]

  • 4. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T, Lin FF, Rao P, Lin MF.
    Prostate; 2003 Jun 01; 55(4):247-58. PubMed ID: 12712404
    [Abstract] [Full Text] [Related]

  • 5. Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
    Deguchi T, Chu TM, Leong SS, Horoszewicz JS, Lee CL.
    Cancer Res; 1986 Aug 01; 46(8):3751-5. PubMed ID: 3731053
    [Abstract] [Full Text] [Related]

  • 6. Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells.
    Lin MF, Lee MS, Zhou XW, Andressen JC, Meng TC, Johansson SL, West WW, Taylor RJ, Anderson JR, Lin FF.
    J Urol; 2001 Nov 01; 166(5):1943-50. PubMed ID: 11586265
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of nonmalignant and malignant human prostate in organ culture.
    Varani J, Dame MK, Wojno K, Schuger L, Johnson KJ.
    Lab Invest; 1999 Jun 01; 79(6):723-31. PubMed ID: 10378515
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5.
    Lopes AD, Davis WL, Rosenstraus MJ, Uveges AJ, Gilman SC.
    Cancer Res; 1990 Oct 01; 50(19):6423-9. PubMed ID: 1698122
    [Abstract] [Full Text] [Related]

  • 9. Codistribution of procathepsin B and mature cathepsin B forms in human prostate tumors detected by confocal and immunofluorescence microscopy.
    Sinha AA, Quast BJ, Wilson MJ, Reddy PK, Gleason DF, Sloane BF.
    Anat Rec; 1998 Oct 01; 252(2):281-9. PubMed ID: 9776083
    [Abstract] [Full Text] [Related]

  • 10. Tyrosine phosphorylation of a 185 kDa phosphoprotein (pp185) inversely correlates with the cellular activity of human prostatic acid phosphatase.
    Lin MF, Meng TC.
    Biochem Biophys Res Commun; 1996 Sep 04; 226(1):206-13. PubMed ID: 8806615
    [Abstract] [Full Text] [Related]

  • 11. Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion.
    Scott LJ, Clarke NW, George NJ, Shanks JH, Testa NG, Lang SH.
    Br J Cancer; 2001 May 18; 84(10):1417-23. PubMed ID: 11355957
    [Abstract] [Full Text] [Related]

  • 12. Histocultures of human prostate tissues for pharmacologic evaluation.
    Wientjes MG, Pretlow TG, Badalament RA, Burgers JK, Au JL.
    J Urol; 1995 Apr 18; 153(4):1299-302. PubMed ID: 7532726
    [Abstract] [Full Text] [Related]

  • 13. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
    Sinha AA, Quast BJ, Korkowski JC, Wilson MJ, Reddy PK, Ewing SL, Sloane BF, Gleason DF.
    Anticancer Res; 1999 Apr 18; 19(4B):2821-9. PubMed ID: 10652560
    [Abstract] [Full Text] [Related]

  • 14. Immunofluorescent localization of an androgen-dependent isoenzyme of prostatic acid phosphatase in rat ventral prostate.
    Terracio L, Rule A, Salvato J, Douglas WH.
    Anat Rec; 1985 Oct 18; 213(2):131-9. PubMed ID: 3907418
    [Abstract] [Full Text] [Related]

  • 15. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
    Song J, Aumüller G, Xiao F, Wilhelm B, Albrecht M.
    Prostate; 2004 Mar 01; 58(4):394-405. PubMed ID: 14968440
    [Abstract] [Full Text] [Related]

  • 16. Identification and characterization of regulatory elements of the human prostatic acid phosphatase promoter.
    Zelivianski S, Igawa T, Lim S, Taylor R, Lin MF.
    Oncogene; 2002 May 23; 21(23):3696-705. PubMed ID: 12032838
    [Abstract] [Full Text] [Related]

  • 17. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML.
    Cancer Res; 1999 Apr 15; 59(8):1987-93. PubMed ID: 10213511
    [Abstract] [Full Text] [Related]

  • 18. [Culturing of normal and tumor cells of the human prostate].
    Cussenot O, Teillac P, Le Duc A, Ketels F, Calvo F.
    Ann Urol (Paris); 1989 Apr 15; 23(6):533-7. PubMed ID: 2482701
    [Abstract] [Full Text] [Related]

  • 19. Identification of cultured, human, malignant, prostatic epithelial cells.
    Stonington OG, Szwec N, Webber M.
    Natl Cancer Inst Monogr; 1978 Dec 15; (49):31-3. PubMed ID: 372822
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.